Increasing UVB radiation at the earth's surface might have adverse effects on in vivo immunologic responses in humans. We prospectively randomized subjects to test whether epicutaneous immunization is altered by prior administration of biologically equalized doses of UV radiation. Multiple doses of antigens on upper inner arm skin (UV protected) were used to elicit contact sensitivity responses, which were quantitated by measuring increases in skin thickness. If a dose of UVB sufficient to induce redness (erythemagenic) was administered to the immunization site prior to sensitization with dinitrochlorobenzene (DNCB), we noted a marked reduction in the degree of sensitization (P < 0.0006) that was highly dose responsive (r = 0.98). Even suberythemagenic UV (less than a visible sunburn) resulted in a decreased frequency of strongly positive responses (32%) as compared to controls (73%) (P = 0.019). The rate of immunologic tolerance to DNCB (active suppression of a subsequent repeat immunization) in the groups that were initially sensitized on skin receiving erythemagenic doses of UV was 31% (P = 0.0003). In addition, a localized moderate sunburn appeared to modulate immunization with diphenylcyclopropenone through a distant, unirradiated site (41% weak responses) as compared to the control group (9%) (P = 0.05). Monitoring antigen presenting cell content in the epidermis revealed that erythemagenic regimens induced CDla-DR+ macrophages and depleted Lrhans cells. In conclusion, relevant and even subcinical levels of UV exposure have significant down modulatory effects on the ability of humans to generate a T-celi-mediated response to antigens introduced through irradiated skin.
ABSTRACT
Increasing UVB radiation at the earth's surface might have adverse effects on in vivo immunologic responses in humans. We prospectively randomized subjects to test whether epicutaneous immunization is altered by prior administration of biologically equalized doses of UV radiation. Multiple doses of antigens on upper inner arm skin (UV protected) were used to elicit contact sensitivity responses, which were quantitated by measuring increases in skin thickness. If a dose of UVB sufficient to induce redness (erythemagenic) was administered to the immunization site prior to sensitization with dinitrochlorobenzene (DNCB), we noted a marked reduction in the degree of sensitization (P < 0.0006) that was highly dose responsive (r = 0.98). Even suberythemagenic UV (less than a visible sunburn) resulted in a decreased frequency of strongly positive responses (32%) as compared to controls (73%) (P = 0.019). The rate of immunologic tolerance to DNCB (active suppression of a subsequent repeat immunization) in the groups that were initially sensitized on skin receiving erythemagenic doses of UV was 31% (P = 0.0003). In addition, a localized moderate sunburn appeared to modulate immunization with diphenylcyclopropenone through a distant, unirradiated site (41% weak responses) as compared to the control group (9%) (P = 0.05). Monitoring antigen presenting cell content in the epidermis revealed that erythemagenic regimens induced CDla-DR+ macrophages and depleted Lrhans cells. In conclusion, relevant and even subcinical levels of UV exposure have significant down modulatory effects on the ability of humans to generate a T-celi-mediated response to antigens introduced through irradiated skin.
With UVB comprising an increasing proportion of the sunlight reaching the earth's surface, the impact of such a change on human health becomes increasingly important to understand. In addition to causing photosensitivity diseases (i.e., lupus, porphyrias, medication reactions) and carcinogenic genetic mutations, mammalian UV exposure alters immunologic responses that normally handle microbial pathogens and UV-induced cancers (1, 2) . For instance, although murine UV-induced cancers can be highly antigenic and are rejected upon transplantation into normal mice (3), mice exposed to subcarcinogenic doses of UV allow progressive tumor growth (4) . Although most other immune functions remained intact, UV-exposed animals could no longer become immunized to normally potent contact allergens (5, 6) . UV exposure resulted not only in a simple failure of immunization, but also in long-term, active suppression of subsequent immunizations to the contact allergen through normal skin (tolerance) (7) (8) (9) (10) (11) . Both the increased UV-induced tumor susceptibility of UV-exposed mice and the unresponsiveness of UV-exposed mice to contact allergens were found to be due to antigen-specific suppressor T lymphocytes (12, 13) .
UV regulation of murine contact sensitivity has held up well as a model of immunologic events occurring in photocarcinogenesis. Epidermal Langerhans cells, an antigen presenting population of dendritic cell lineage present in the epidermis (14) , have a potent capacity to initiate contact sensitivity reactions (15, 16) , as well as tumor rejection (17) . However, purified Langerhans cells exposed to UV are no longer able to induce T-lymphocyte proliferation (18) , possibly through alterations of adhesion molecule expression (19) . The net result of UV exposure is that immunization (to contact, tumor, or microbial antigens) through the skin results in persistent antigen-specific unresponsiveness to the antigens (20) (21) (22) (23) . Depression in the ability of T cells to react to new peptide sequences generated as a result of a UVinduced genetic mutation could then result in tolerance rather than rejection of UV carcinoma cells bearing such abnormal gene products (24) .
Previous studies on whether UV modulates the contact sensitization potential of human skin in vivo have suggested slightly reduced (25) (26) (27) (28) (29) (30) (31) or unaltered responses (32, 33) . However, none of these studies is conclusive due to the use of subjective assessments, to testing of the response by using skin of patients with skin disease or skin that had also recently received UV exposure, to insufficient n for statistical analysis, or to lack of appropriate control groups.
We modified a highly quantitative and sensitive method for assessing dinitrochlorobenzene (DNCB) contact sensitivity in human skin (34) . Prospectively randomized groups were sensitized through normal skin or skin irradiated with various doses of individually biologically equalized doses of UV. We found that UV exposure in humans resulted in highly significant, dose-responsive decreases in immunologic responsiveness. Of additional concern are our findings that levels of UV exposure below clinical detectability can impair immune responsiveness and that a localized sunburn can alter T-cell responses at distant, unirradiated sites. ule. Individuals were of skin type I, II, or III, without history of chronic disease and not currently on medication.
MATERIALS AND METHODS
Individuals received either no UV radiation or one of three localized UV exposure regimens. A portable UVB phototherapy device (Dermacontrol, Frankfort, IL) containing six FS40 bulbs emitted 0.3 mJ/cm2 at a 10-inch (1 inch = 2.54 cm) source-to-skin distance. An LMHO6C meter (National Biological, Cleveland) equipped with an IL SEE1240 detector fitted with a W wide-angle quartz diffuser and a SCS280 filter (International Light, Newburyport, MA) was used. The minimal erythemal dosage (MED) was determined for each subject, such that biologically equivalent amounts of UVB were administered. Except for the 3 x 5-inch exposure area on the left buttock, all areas of the body were draped. Two groups were exposed 4 days in a row, with the first group receiving 0.75 of the MED (0.75MED X 4) and the second group receiving 2 times the MED each day (2MED x 4) ( Table 1 ). These subjects were sensitized to contact allergens immediately following the last UV exposure (day 4). A third group received 4 MED on the 1st day only (4MED x 1). These subjects were sensitized on the 3rd day after UV exposure (day 3). To control for diminished levels of contact sensitization that occurs in menstruating women except during midcycle (35) , all female subjects were sensitized 14 days after the onset of menses.
Sensitization. DNCB was applied to the left buttock, which had received the UV exposure [ Scoring of Contact Sensitivity Elicitation. A visual subjective score (i-v) scales intensity as follows: (i) no reaction, (ii) mild, macular erythema, (iii) moderate erythema, occasionally with papulation, (iv) strong erythematous reaction (in- cludes edematous vesicular changes), (v) extreme or spreading reaction (includes bullous or ulcerative reaction).
In addition to the subjective assessment, we used an objective assessment of skin edema. The skin fold thickness was determined by using a micrometer with spring-loaded calipers (Mitutoyo Manufacturing, Tokyo), recording the skin thickness in millimeters at each site before and 48 hr after the patch was applied. The increase in skin thickness over the 48-hr period was calculated for each site by subtracting the prechallenge thickness from the 48-hr postchallenge thickness. The "mm increase sum" is derived from the addition of the increases in skin thickness of each of the four concentrations for each allergen and allows the entire dose-response curve (see Fig. 1 ) to be approximated as a single value (see Fig. 2 ). Photographs were also obtained.
Langerhans Cell Quantitation in Sheets. Punch biopsies (4 mm) were taken on the day of sensitization-one from the exposed buttock and one from the protected buttock. A system and by measuring the increase in skin thickness at the reaction site (Fig. 1) . A single acute moderate sunburn with 4MED UV 3 days before application of the sensitizer also resulted in significant reductions in contact sensitivity responses, whether expressed as mean visual score (P < 0.0003 at the 12.5-pg test site), or as mean increase in skin thickness (P < 0.0006 at 12.5 pg) (data not shown).
Analysis of Overall Individual Responses Reveals Decreased
Frequencies of Fully Successful Immunizations in All UV Exposure Groups. The overall response of each individual (sum of increases in skin thickness across the four challenge concentrations) was used to determine the frequency of clearly positive responses, weak responses, and negative responses. A negative response to DNCB was defined as that which is indistinguishable from irritant responses to DNCB in unsensitized subjects [a sum of mm increases in skin thickness that was <2 SD above the mean increase in skin thickness that occurs in response to DNCB in previously unsensitized individuals (challenge only)] (Fig. 2) . To determine the expected range of positive responses in control subjects sensitized on normal skin (No UV; Fig. 2 (Fig. 2, upper line) . Only 9o of the DNCB-sensitized, no UV control group demonstrated weak responses; that is, sensitization on normal skin generally resulted in a strongly positive or a totally negative response.
The distribution of frequencies of DNCB responses of the UV exposure groups was significantly different from that of the control no UV group (Fig. 2) . The percentage of strong positive responses dropped from 73% in the no UV control group to 32% in the suberythemagenic group (P = 0.019), to 5% in the 2MED x 4 group (P < 0.0001), and to 27% in the 4MED x 1 group (P = 0.011) (Pearson's uncorrected x2 test) ( Table 2 ). The frequency of positive responses was reduced in direct proportion to the total number of mJ/cm2 delivered to the skin in the immediately preceding period, with a high negative correlation coefficient of -0.98. These (second sensitization) to DNCB on the normal skin of the right (never received UV) buttock and rechallenged on the upper inner arms. Individuals continuing to exhibit a negative response were defined as tolerant to DNCB. To estimate the frequency of tolerance in the original study population, the frequency of tolerance among tested nonresponders was multiplied by the frequency of nonresponders (Table 3) . Whereas only 7.0o of subjects who received primary sensitization on normal skin were calculated to be tolerant to DNCB, 31% of individuals receiving primary sensitization through skin exposed to erythemagenic doses of UV were calculated to be tolerized ( (Figs. 3 and 4) . Negative responses are less than the mean + 2 SD of the subjects receiving antigen challenge without sensitization (irritant response). tPrimary nonresponders resensitized to DNCB on normal skin.
Tolerance is a negative response upon rechallenge.
tOverall frequency of tolerance is the frequency of subjects who are both primary and secondary nonresponders. n = 3 tolerant among 11 primary nonresponders retested among 103 subjects initially sensitized on unexposed normal left buttock skin. n = 5 tolerant among 10 primary nonresponders retested from 42 subjects initially sensitized to DNCB on left buttock skin that had been exposed to erythemagenic doses of UV (P = 0.0003 by x2 test).
The distribution of responses in the 0.75 and 2MED x 4 groups was not different from that of the no UV control group, which exhibited 64% strongly positive immunizations, 9% weakly positive, and 27% negative responses (P = 0.81 and 0.54, respectively) ( Table 2) (Fig. 3) . On the other hand, a single 4MED exposure did appear to modulate the distribution of contact sensitivity responses (P = 0.05). The frequency of 4MED x 1 weakly positive DPCP responses was 41%, whereas only 9%o of the no UV control group had weakly positive responses (Table 2) . Thus, a single localized sunburn in one site may systemically alter epicutaneous immunizations at a distant, UV-protected site. However, the modest intensity of the distant effect cannot account for the profound reductions that occur by contact sensitization directly through UV-exposed skin.
Reduced Langerhans Cell Density and Induction of CDla-DR+ Cells in Sunburned Epidermis. Murine experiments have demonstrated differences in the ability to contact sensitize depending on whether the mice are exposed to low-dose UV (40-50 mJ/cm2) or high-dose UV (.100 mJ/ cm2) (7, 8 decrease in each) (P < 0.0001) (Fig. 4) . Thus, it appears that low-dose murine UV exposures that resulted in >70% depletion of Langerhans cells (7) were more equivalent to the human 2MED and 4MED exposure regimens.
Langerhans cell depletion alone, however, may not totally account for UV induction of antigen-specific tolerance (36) . A population of UV-induced macrophages appears in UVexposed human (37) and murine (38) epidermis. In humans, the macrophages are responsible for preferential activation of suppressor cells (39) and in mice they are critical for tolerance induction (38) . Induction of CDla-DR+ epidermal cells was observed in both of the erythemagenic UV-exposure regimens (P = 0.0006 and 0.0567) but not with the suberythemagenic regimen (P = 0.9457) (Fig. 4) . DISCUSSION Because of progressive thinning of stratospheric ozone, an ever-increasing proportion of solar energy reaching the earth's surface is composed of highly active UVB radiation. Increasing UVB flux is projected to have a major impact on skin cancer health expenditures in the near future (40) . Our data demonstrating that UV exposure also has a major impact on the in vivo functioning of the human immune system suggest that additional expenditures may be engendered as a result of increasing immune dysfunction.
Even daily exposure to levels of UV below the erythemal threshold (0.75MED) appeared to down modulate immune responsiveness, which makes it difficult for people to gauge a "safe" level of exposure. Brief, inadvertent, midday summer or high-altitude exposures can easily deliver a 0.75MED dose. The daily 2MED erythemagenic dose of UV used here models the level of exposure received by individuals in whom a low-grade redness is evident as a result of outdoor exposure in association with school recess, work, conditioning, recreation, or cosmesis, or as a result of exposure in UVA tanning salons that are commonly equipped with UVB-contaminated bulbs. The 4MED erythemagenic dose more closely models 8500 Immunology: Cooper et al.
---an acute weekend or vacation sunburn that is not severe enough to blister, but that may result in a slight peel, again a common and relevant occurrence. The ability of such a local sunburn to systemically modulate distal immune responses (Table 2 ) may be consonant with the work of Hersey et al. (33) , which demonstrated suppressor cells for pokeweed mitogen-induced in vitro immune responsiveness in subjects exposed to "sun-baking" for 2 weeks in Australia. Of note is that the acquisition of malignant melanoma correlates with the occurrence of an acute sunburn in childhood (41); altered immune responsiveness to new peptide sequences produced by UV-mutated genes that might also function as tumor antigens (24, 42) could be expressed as tolerance rather than rejection (Table 3 ) (30) .
The sensitizing dose of DNCB (30 ,ug in 48 jl) was chosen to have our data read out on the linear portion of the curve of sensitization rate vs. sensitizing dose (34) . That this approach allowed detection of immunomodulation was confirmed by our finding of only 5% fully successful immunizations after four -30 mJ exposures (Tables 1 and 2 ). This result differs from a related study, which only demonstrated a trend toward a reduced immunization rate through skin previously exposed to four fixed doses of 144 mJ/cm2 of UVB per day (6/10 successful immunizations) (30) . A difference in sensitivity of the bioassay is likely; Yoshikawa et al. (30) sensitized and challenged their subjects to much higher doses of DNCB (2000 and 50 Ag, respectively). Increased sensitivity of our assay may also be due to control of additional variables: MED testing to equalize optical penetration of UV between individuals, immunizing only midcycle females (35) , and using a randomized study design.
What mechanisms occur in sunburned skin that might account for our findings? Acute erythemagenic UV injury to the skin is characterized by erythema and induration due to mediator release (43) , endothelial ELAM-1 induction (44), leukocytic infiltration (45), keratinocyte necrosis and Langerhans cell depletion (7, 18) . Infiltrating macrophages (37) preferentially activate CD4+ (suppressor inducer) T lymphocytes to down regulate lymphocyte activation (39) , and an analogous population plays a critical role in the induction of murine tolerance (38) . In addition, UV-damaged Langerhans cells may deliver negative signals by inducing clonal anergy or preferential TH2 expansion (21) . Whatever the mechanism, however, the common occurrence of UVinduced (46) failure to sensitize to DNCB in skin cancer patients (30) suggests that UV induces a relevant degree of immunologic injury in humans.
In conclusion, commonly experienced levels of UV exposure render the skin of 95% of individuals diminished in their ability to mount a form of delayed-type hypersensitivity (contact sensitivity) if the initial immunization occurs in the UV-exposed skin. Thirty percent appear particularly susceptible and become unable to generate a contact sensitivity response even after a repeated sensitization (tolerance). Increased understanding of this area may allow better planning of strategies to minimize adverse UVB effects on skin cancer, immunization programs, microbial immunity, and photosensitivity diseases.
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